RC

Roger Shen-Chu Chen

BS Bristol-Myers Squibb: 59 patents #15 of 3,969Top 1%
📍 Edison, NJ: #16 of 1,355 inventorsTop 2%
🗺 New Jersey: #655 of 69,400 inventorsTop 1%
Overall (All Time): #40,418 of 4,157,543Top 1%
59
Patents All Time

Issued Patents All Time

Showing 51–59 of 59 patents

Patent #TitleCo-InventorsDate
6476052 Isoindolines, method of use, and pharmaceutical compositions George W. Muller, David I. Stirling 2002-11-05
6395754 Substituted 2-(2,6-dioxopiperidin-3-yl)- phthalimides and 1-oxoisoindolines and method of reducing TNF&agr; levels George W. Muller, David I. Stirling 2002-05-28
6335349 Substituted 2(2,6-dioxopiperidin-3-yl)isoindolines George W. Muller, David I. Stirling 2002-01-01
6316471 Isoindolines, method of use, and pharmaceutical compositions George W. Muller, David I. Stirling 2001-11-13
6281230 Isoindolines, method of use, and pharmaceutical compositions George W. Muller, David I. Stirling 2001-08-28
5955476 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels George W. Muller, David I. Stirling, Hon-Wah Man 1999-09-21
5874448 Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNF.alpha. levels George W. Muller, David I. Stirling, Hon-Wah Man 1999-02-23
5798368 Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines and method of reducing TNF.alpha. levels George W. Muller, David I. Stirling 1998-08-25
5635517 Method of reducing TNF.alpha. levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines George W. Muller, David I. Stirling 1997-06-03